Retraction: Proteasome Inhibition Blocks NF-{kappa}B and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
Source: Molecular Cancer Therapeutics - Category: Cancer & Oncology Tags: Retraction Source Type: research